ALYSSA MARTYAK: Open Payments
NPI 1033800941 · ALTOONA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,330 in 131 payments from 13 companies in 2025. Trend: 2023 $564 · 2024 $1,066 · 2025 $2,330
Food & beverage: $2,330
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $620 |
| Ardelyx, Inc. | 19 | $491 |
| Janssen Biotech, Inc. | 13 | $337 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 21 | $236 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $181 |
| Madrigal Pharmaceuticals | 7 | $142 |
| Ipsen Biopharmaceuticals, Inc | 6 | $110 |
| Celltrion USA Inc. | 3 | $76 |
| Regeneron Healthcare Solutions, Inc. | 3 | $71 |
| Intercept Pharmaceuticals, Inc. | 1 | $19 |
Products named: IBSRELA, TREMFYA, RINVOQ, XIFAXAN, REZDIFFRA, IQIRVO, DUPIXENT, ENTYVIO.
Industry payments across PA — which companies pay providers there.
